scholarly journals A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial

2021 ◽  
Vol 158 ◽  
pp. 17-26
Author(s):  
Rachel Galot ◽  
Christophe Le Tourneau ◽  
Esma Saada-Bouzid ◽  
Amaury Daste ◽  
Caroline Even ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Study ◽  
Metastatic Squamous Cell Carcinoma

scholarly journals Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck

Cancer ◽  
2001 ◽  
Vol 92 (9) ◽  
pp. 2364-2373 ◽  
Author(s):  
Jennifer E. Tseng ◽  
Bonnie S. Glisson ◽  
Fadlo R. Khuri ◽  
Dong M. Shin ◽  
Jeffrey N. Myers ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Study ◽  
Metastatic Squamous Cell Carcinoma
Sign in / Sign up

Export Citation Format

Share Document